BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23829615)

  • 1. Interferon for hepatitis C: where it has been and where it is going.
    Koretz RL
    Immunotherapy; 2013 Jul; 5(7):673-5. PubMed ID: 23829615
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
    Feld JJ; Hoofnagle JH
    Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future therapies for hepatitis C.
    Pawlotsky JM; Gish RG
    Antivir Ther; 2006; 11(4):397-408. PubMed ID: 16856613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hepatitis C: advances and consensus].
    Lerebours E; Marcellin P; Dhumeaux D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B5-6. PubMed ID: 12180308
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b].
    Sakuma I; Enomoto N; Asahina Y; Kurosaki M; Sato C
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):930-5. PubMed ID: 7563904
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
    Main J
    J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction: combination antiviral therapy in chronic hepatitis C.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():1-2. PubMed ID: 8720285
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of hepatitis C virus genotype 4.
    Abdo AA; Lee SS
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C: ribavirin and/or interferon?
    Heathcote J
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S71-5. PubMed ID: 8986103
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of glomerulonephritis associated with hepatitis C virus in patient with cirrhosis: only pegylated interferon and ribavirin.
    Taş A; Koçak E; Akbal E; Köklü S
    Chin Med J (Engl); 2011 May; 124(10):1600. PubMed ID: 21740828
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategies for hepatitis C therapeutic intervention: now and next.
    Tan SL; He Y; Huang Y; Gale M
    Curr Opin Pharmacol; 2004 Oct; 4(5):465-70. PubMed ID: 15351350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options for chronic hepatitis C infection.
    James DG
    J Antimicrob Chemother; 1995 Oct; 36(4):591-3. PubMed ID: 8591933
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel interferons for treatment of hepatitis C virus.
    Clark V; Nelson DR
    Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative interferons and immunomodulators in the treatment of hepatitis C.
    Alao H; Jake Liang T
    Liver Int; 2014 Feb; 34 Suppl 1():133-8. PubMed ID: 24373090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon-ribavirin therapy.
    Ogata K; Kashiwagi T; Iwahashi J; Hara K; Honda H; Ide T; Kumashiro R; Kohara M; Sata M; Watanabe H; Hamada N
    Arch Virol; 2008; 153(8):1575-9. PubMed ID: 18592133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C.
    el-Sayed AM; Sharara AI
    J Med Liban; 2001; 49(2):71-7. PubMed ID: 11910970
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic hepatitis C virus management: 2000-2005 update.
    Hughes CA; Shafran SD
    Ann Pharmacother; 2006 Jan; 40(1):74-82. PubMed ID: 16368925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis C: therapeutic perspectives].
    Trépo C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B297-302. PubMed ID: 12180304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.